Cardama Alfonso Quintas
Insider CIK 1760104 · TCRR Chief Medical Officer · FHTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-30 | 2026-02-02 | 300,000 | $5.71 | $1.71M | 300,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2025-01-22 | 2025-01-24 | 125,000 | $4.37 | $546.3K | 125,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2024-01-24 | 2024-01-25 | 60,000 | $3.06 | $183.6K | 60,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-09-11 | 2023-09-13 | 272,000 | $7.57 | $2.06M | 272,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 11,775 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,489 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 9,549 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 1,409 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 31,582 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 114,700 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 90,720 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 42,346 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 70,649 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer | 2023-06-01 | 2023-06-01 | 109,459 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 70,649 | — | $0 | 70,649 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 11,775 | — | $0 | 11,775 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-13 | 2022-12-13 | 4,752 | $1.06 | $5.0K | 109,459 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-12 | 2022-12-13 | 4,586 | $1.10 | $5.0K | 114,211 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-09 | 2022-12-13 | 4,461 | $1.13 | $5.0K | 118,797 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-08 | 2022-12-09 | 4,014 | $1.26 | $5.1K | 123,258 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-07 | 2022-12-09 | 3,928 | $1.28 | $5.0K | 127,272 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-06 | 2022-12-07 | 3,778 | $1.33 | $5.0K | 131,200 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-05 | 2022-12-07 | 3,686 | $1.37 | $5.0K | 134,978 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-02 | 2022-12-05 | 3,636 | $1.39 | $5.1K | 138,664 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 69,025 | — | $0 | 1,409 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 17,545 | — | $0 | 6,489 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 8,815 | — | $0 | 9,549 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2022-12-01 | 2022-12-05 | 95,385 | — | $0 | 142,300 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 68,792 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 1,103 | — | $0 | 1,103 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 3,308 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 22,931 | — | $0 | 22,931 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 4,486 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 816 | — | $0 | 816 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 96,514 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 17,548 | — | $0 | 17,548 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 5,799 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 1,933 | — | $0 | 1,933 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 205,503 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 68,501 | — | $0 | 68,501 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 114,700 | — | $0 | 114,700 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2021-12-09 | 2021-12-10 | 43,000 | $0.74 | $31.8K | 31,582 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2021-12-09 | 2021-12-10 | 43,000 | $0.74 | $31.8K | 46,915 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2021-08-31 | 2021-12-10 | 164 | $14.26 | $2.3K | 3,915 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2021-02-28 | 2021-03-08 | 708 | $16.12 | $11.4K | 3,751 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2020-12-10 | 2020-12-11 | 101,000 | — | $0 | 101,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2020-08-31 | 2021-03-08 | 1,118 | $10.10 | $11.3K | 3,043 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2020-02-28 | 2020-03-27 | 1,082 | $10.10 | $10.9K | 1,925 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-12-19 | 2019-12-20 | 72,100 | — | $0 | 72,100 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2019-08-30 | 2020-03-27 | 843 | $12.75 | $10.7K | 843 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-04-11 | 2019-04-12 | 211,302 | — | $0 | 211,302 | SEC↗ |